Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.290
+0.007 (2.55%)
At close: Feb 21, 2025, 4:00 PM
0.285
-0.005 (-1.72%)
After-hours: Feb 21, 2025, 7:57 PM EST
Oragenics Employees
Oragenics had 5 employees as of December 31, 2023. The number of employees decreased by 1 or -16.67% compared to the previous year.
Employees
5
Change (1Y)
-1
Growth (1Y)
-16.67%
Revenue / Employee
n/a
Profits / Employee
-$3,993,245
Market Cap
3.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
OGEN News
- 12 days ago - Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment - GlobeNewsWire
- 18 days ago - Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025 - GlobeNewsWire
- 4 weeks ago - Oragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO - GlobeNewsWire
- 2 months ago - Oragenics, Inc. Announces Conversion of Preferred Shares and Elimination of Liquidation Preference - GlobeNewsWire
- 4 months ago - Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit - GlobeNewsWire
- 4 months ago - Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation - GlobeNewsWire
- 4 months ago - Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002 - GlobeNewsWire
- 6 months ago - Oragenics, Inc. Announces Closing of Public Offering - GlobeNewsWire